Legal Issues Related to Rare Diseases

The absence of lawful controls on treating the uncommon rare diseases in numerous nations in the world, because of patients and their families are getting affected with various diseases obstructions when requesting for professional help. The first country to pass and approve the Orphan Drug Act in USA, followed by Japan in 1993, and eventually the European Union in 2000. The absence of a special International Disease Classification about disease leading to the IDC blocks the usage of a framework for the patients who are experiencing these diseases in the world. The main motto is to focus on rare diseases from the aspect of acceptable strategies or unsatisfactory social results is of critical need. 

  • Regulations on rare diseases
  • Ethical issues

Related Conference of Legal Issues Related to Rare Diseases

May 10-11, 2021

4th Global Experts Meeting on Infectious Diseases

Singapore City, Singapore
May 27-28, 2021

7th Rare Diseases and Orphan Drugs

Vienna, Austria
July 19-20, 2021

13th Global Infections Conference

Tokyo, Japan
September 06-07, 2021

11th World Congress on Rare Diseases and Orphan Drugs

Berlin, Germany
October 21-22, 2021

International Conference on Tropical Diseases and Cure

Zurich, Switzerland
November 22-23, 2021

3rd World Congress on Advancements in Tuberculosis and Lung Diseases

Singapore City, Singapore
February 07-08, 2022

9th International Congress on Infectious Diseases

Aberdeen, UK

Legal Issues Related to Rare Diseases Conference Speakers

Recommended Sessions

Related Journals

Are you interested in